| Name | bruceantarin |
|---|---|
| Synonyms | Picras-3-en-21-oic acid,15-(benzoyloxy)-13,20-epoxy-3,11,12-trihydroxy-2,16-dioxo-,methyl ester,(11beta,12alpha,15beta) |
| Description | Bruceantarin is a potent antineoplastic agent. Bruceantarin can be used for leukemia and breast cancer research[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Bruceantarin exhibits potent antineoplastic activity in both MCF-7 and MDA-MB-231 cells, with IC50 values of 0.144 ± 0.039 μM and 0.238 ± 0.021, respectively[1]. |
| Density | 1.52g/cm3 |
|---|---|
| Boiling Point | 765ºC at 760 mmHg |
| Molecular Formula | C28H30O11 |
| Molecular Weight | 542.53100 |
| Flash Point | 255.4ºC |
| Exact Mass | 542.17900 |
| PSA | 165.89000 |
| LogP | 0.86460 |
| Index of Refraction | 1.648 |